参考文献/References:
[1]MEYER KD, SALETORE Y, ZUMBO P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons [J]. Cell, 2012, 149(7): 1635-1646.
[2]WANG J, SHA Y, SUN T. m6A modifications play crucial roles in glial cell development and brain tumorigenesis [J]. Front Oncol, 2021, 11: 611660.
[3]CHANG YZ, CHAI RC, PANG B, et al. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma [J]. Cancer Lett, 2021, 511: 36-46.
[4]ZHU X, YANG H, ZHANG M, et al. YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells [J]. Cancer Cell Int, 2021, 21(1): 645.
[5]TAO M, LI X, HE L, et al. Decreased RNA m6A methylation enhances the process of the epithelial mesenchymal transition and vasculogenic mimicry in glioblastoma [J]. Am J Cancer Res, 2022, 12(2): 893-906.
[6]ZEECKI JP, KARAMBIZI D, FAJARDO JE, et al. miRNA-mediated loss of m6A increases nascent translation in glioblastoma [J]. PLoS Genet, 2021, 17(3): e1009086.
[7]ZHANG S, ZHAO S, QI Y, et al. SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner [J]. Mol Ther Nucleic Acids, 2022, 27: 699-717.
[8]WEI C, WANG B, PENG D, et al. Pan-cancer analysis shows that alkbh5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas [J]. Front Immunol, 2022, 13: 849592.
[9]LI L, ZHOU M, CHEN B, et al. ALKBH5 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating PTEN expression in an m6A-dependent manner [J]. Ecotoxicol Environ Saf, 2021, 224: 112686.
[10]CHAI RC, CHANG YZ, CHANG X, et al. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma [J]. J Hematol Oncol, 2021, 14(1): 109.
[11]FANG R, CHEN X, ZHANG S, et al. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma [J]. Nat Commun, 2021, 12(1): 177.
[12]YARMISHYN AA, YANG YP, LU KH, et al. Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1 [J]. Cancer Cell Int, 2020, 20(1): 597.
[13]CONG P, WU T, HUANG X, et al. Identification of the role and clinical prognostic value of target genes of m6a rna methylation regulators in glioma [J]. Front Cell Dev Biol, 2021, 9: 709022.
[14]ZHONG C, TAO B, YANG F, et al. Histone demethylase JMJD1C promotes the polarization of M1 macrophages to prevent glioma by upregulating miR-302a [J]. Clin Transl Med, 2021, 11(9): e424.
[15]KOWALSKI-CHAUVEL A, LACORE MG, Arnauduc F, et al. The m6A RNA demethylase ALKBH5 promotes radioresistance and invasion capability of glioma stem cells [J]. Cancers (Basel), 2020, 13(1): 40.
[16]LI F, CHEN S, YU J, et al. Interplay of m6 A and histone modifications contributes to temozolomide resistance in glioblastoma [J]. Clin Transl Med, 2021, 11(9): e553.
[17]LI XD, WANG MJ, ZHENG JL, et al. Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multi-forme cells [J]. Cancer Sci, 2021, 112(11): 4543-4552.
[18]XIAO L, LI X, MU Z, et al. FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155/23a cluster-MXI1 feedback circuit in glioma [J]. Cancer Res, 2020, 80(18): 3945-3958.
[19]RADOUL M, LEWIN L, COHEN B, et al. Genetic manipulation of iron biomineralization enhances MR relaxivity in a ferritin-M6A chimeric complex [J]. Sci Rep, 2016, 6: 26550.
[20]GUAN S, HE Y, SU Y, et al. A risk signature consisting of eight m6a methylation regulators predicts the prognosis of glioma [J]. Cell Mol Neurobiol, 2022, 42(8): 2733-2743.
[21]ZHENG J, WANG X, QIU Y, et al. Identification of critical m6A RNA methylation regulators with prognostic value in lower-grade glioma [J]. Biomed Res Int, 2021, 2021: 9959212.
[22]CHAI RC, WU F, WANG QX, et al. m6A RNA methylation regulators contribute to malignant progression and have clinical prognos- tic impact in gliomas [J]. Aging (Albany NY), 2019, 11(4): 1204-1225.
[23]ZHAO WJ, OU GY, LIN WW. Integrative analysis of neuregulin family members-related tumor microenvironment for predicting the prognosis in gliomas [J]. Front Immunol, 2021, 12: 682415.
[24]BAI Z, WANG X, ZHANG Z. Establishment and validation of a 5 m6A RNA methylation regulatory gene prognostic model in low-grade glioma [J]. Front Genet, 2022, 13: 655169.
[25]CHEN Y, GUO Y, LI S, et al. Identification of N6-methyladenosine-related lncRNAs as a prognostic signature in glioma [J]. Front Oncol, 2022, 12: 789283.
[26]NGUYEN QH, NGUYEN T, LE DH. Identification and validation of a novel three hub long noncoding RNAs with m6A modification signature in low-grade gliomas [J]. Front Mol Biosci, 2022, 9: 801931.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(05):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(05):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(05):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(05):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(05):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(05):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(05):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]